Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Sullivan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 9, 2017
Analytic characterization of biosimilarsPeter M Sullivan, Lisa M DiGrazia
Autophagy|January 31, 2019
SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasisYungang Lan, Peter M Sullivan, Fenghua Hu
Progress in Transplantation (Aliso Viejo, Calif.)|August 27, 2015
Hyperuricemia and gout in solid-organ transplant: update in pharmacological managementPeter M Sullivan, Asch William, Eric M Tichy
Journal of Neurochemistry|June 23, 2017
The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and CXiaolai Zhou, Peter M Sullivan, Lirong Sun, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 30, 2018
The Interaction Between Progranulin with Sortilin and the LysosomeXiaolai Zhou, Peter M Sullivan, Daniel H Paushter, et al.
Frontiers in Immunology|December 6, 2021
Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T CellsPeter M Sullivan, Steven James Reed, Vandana Kalia, et al.
Acta Neuropathologica Communications|May 20, 2016
The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathwayPeter M Sullivan, Xiaolai Zhou, Adam M Robins, et al.
Molecular Cancer Therapeutics|July 25, 2022
FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic RhabdomyosarcomaPeter M Sullivan, Rajesh Kumar, Wei Li, et al.
Brain : a Journal of Neurology|June 24, 2020
A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelinationTuancheng Feng, Rory R Sheng, Santiago Solé-Domènech, et al.
Cell Reports. Medicine|September 29, 2023
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 9, 2017
Analytic characterization of biosimilarsPeter M Sullivan, Lisa M DiGrazia
Autophagy|January 31, 2019
SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasisYungang Lan, Peter M Sullivan, Fenghua Hu
Progress in Transplantation (Aliso Viejo, Calif.)|August 27, 2015
Hyperuricemia and gout in solid-organ transplant: update in pharmacological managementPeter M Sullivan, Asch William, Eric M Tichy
Journal of Neurochemistry|June 23, 2017
The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and CXiaolai Zhou, Peter M Sullivan, Lirong Sun, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 30, 2018
The Interaction Between Progranulin with Sortilin and the LysosomeXiaolai Zhou, Peter M Sullivan, Daniel H Paushter, et al.
Frontiers in Immunology|December 6, 2021
Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T CellsPeter M Sullivan, Steven James Reed, Vandana Kalia, et al.
Acta Neuropathologica Communications|May 20, 2016
The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathwayPeter M Sullivan, Xiaolai Zhou, Adam M Robins, et al.
Molecular Cancer Therapeutics|July 25, 2022
FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic RhabdomyosarcomaPeter M Sullivan, Rajesh Kumar, Wei Li, et al.
Brain : a Journal of Neurology|June 24, 2020
A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelinationTuancheng Feng, Rory R Sheng, Santiago Solé-Domènech, et al.
Cell Reports. Medicine|September 29, 2023
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.
Pageof 1